SEC Form 4 · accession 0001382963-16-000219
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Geraghty
Director
Period of report
Aug 2, 2016
Accepted (ET)
Aug 3, 2016 · 8:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock, par value $0.01F1,F2 | Aug 2, 2016 | A | 10,613 | $0.00 | A | 54,153 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares will vest in full at the 2017 Annual Shareholders meeting.
- F2The amount of securities beneficially owned by the reporting person was understated by 461 shares in the reporting person's last Form 4 due to an administrative error.